29224

    544292

    ONESOURCE

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ONESOURCE SPECL PHARMA L Share Price Today

    ONESOURCE SPECL PHARMA L is currently trading at ₹1576, up by ₹18.9 from the previous close. The stock touched an intraday high of ₹1586.00 and a low of ₹1545.00 during the latest trading session. Over the past one year, ONESOURCE SPECL PHARMA L has delivered a loss of 17.05%, while the stock has declined 6.37% in the last one month.

    ONESOURCE SPECL PHARMA L performance

    Today’s low Today’s high
    ₹ 1545.00 ₹ 1586.00
    ₹ 1576.00
    52 week low 52 week high
    ₹ 1057.00 ₹ 1925.00
    ₹ 1576.00
    Open Price ₹ 1548.00
    Prev. Close ₹ 1557.10
    Volume (Shares) 151582.00
    Total traded value ₹ 2388.93
    Upper Circuit ₹ 1868.50
    Lower Circuit ₹ 1245.70
    info

    Investment Returns

    Over 1 Month -6.37% Over 3 Months -10.69% Over 6 Months 39.03% Over 1 Year -17.05%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ONESOURCE SPECL PHARMA L fundamentals


    • Market cap (Cr) 18,072.40
    • P/E Ratio (TTM) 373.70
    • Beta -0.26
    • Book Value / share 518.95
    • Return on equity 3.22%
    • EPS (TTM) 4.63
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 51.23
    info icon alternate text
    • Market cap (Cr) 18,099.40
    • P/E Ratio (TTM) 373.70
    • Beta -0.21
    • Book Value / share 518.95
    • Return on equity 3.22%
    • EPS (TTM) 4.63
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 51.23
    info icon alternate text

    ONESOURCE SPECL PHARMA L Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 446.47
    Operating Expense 399.03
    Net Profit 51.23
    Net Profit Margin (%) 11.47
    Earnings Per Share (EPS) 4.47
    EBITDA 117.93
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 418.96
    Operating Expense 401.24
    Net Profit 21.48
    Net Profit Margin (%) 5.12
    Earnings Per Share (EPS) 1.87
    EBITDA 78.47
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 290.22
    Operating Expense 349.94
    Net Profit -62.19
    Net Profit Margin (%) -21.42
    Earnings Per Share (EPS) -5.43
    EBITDA 10.37
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 375.19
    Operating Expense 341.12
    Net Profit 37.10
    Net Profit Margin (%) 9.88
    Earnings Per Share (EPS) 3.24
    EBITDA 104.62
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 321.01
    Operating Expense 301.45
    Net Profit 24.82
    Net Profit Margin (%) 7.73
    Earnings Per Share (EPS) 2.17
    EBITDA 85.13
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 1405.38
    Operating Expense 1393.76
    Net Profit 21.21
    Net Profit Margin (%) 1.50
    Earnings Per Share (EPS) 1.85
    EBITDA 278.59
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 1299.59
    Operating Expense 1226.48
    Net Profit 19.31
    Net Profit Margin (%) 1.48
    Earnings Per Share (EPS) 1.75
    EBITDA 274.70
    Effective Tax Rate (%) 193.19
    Particulars MAR 2024 (Values in Cr)
    Revenue 171.92
    Operating Expense 425.15
    Net Profit -390.40
    Net Profit Margin (%) -227.08
    Earnings Per Share (EPS) -93.97
    EBITDA -199.21
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 38.71
    Operating Expense 312.56
    Net Profit -799.11
    Net Profit Margin (%) -2064.35
    Earnings Per Share (EPS) -200.69
    EBITDA -316.32
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 513.90
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.21
    EBITDA Margin 33.51
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 98.68
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.21
    EBITDA Margin -45.49
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 195.87
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.12
    EBITDA Margin -410.47
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 333.49
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.86
    EBITDA Margin -70.30
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 5029.28
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.72
    EBITDA Margin -328.85
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 517.36
    ROE % 3.22
    ROCE % 5.21
    Total Debt to Total Equity 0.24
    EBITDA Margin 29.71
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 99.19
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.21
    EBITDA Margin -45.51
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1961.88
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.12
    EBITDA Margin -298.97
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 259.75
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.86
    EBITDA Margin -69.15
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 5045.70
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.72
    EBITDA Margin -332.12
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 300.89
    Total Assets 7550.24
    Total Liabilities 7550.24
    Total Equity 5880.57
    Share Outstanding 11
    Price to Book Ratio 3.38
    Return on Assets (%) -0.23
    Return on Capital (%) -0.27
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 60.32
    Total Assets 1308.61
    Total Liabilities 1308.61
    Total Equity 395.71
    Share Outstanding 4
    Price to Book Ratio 0.00
    Return on Assets (%) -29.89
    Return on Capital (%) -40.84
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 79.82
    Total Assets 2008.80
    Total Liabilities 2008.80
    Total Equity 785.45
    Share Outstanding 4
    Price to Book Ratio 0.00
    Return on Assets (%) -39.81
    Return on Capital (%) -49.31
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 169.73
    Total Assets 2442.35
    Total Liabilities 2442.35
    Total Equity 1012.47
    Share Outstanding 3
    Price to Book Ratio 0.00
    Return on Assets (%) -9.46
    Return on Capital (%) -10.67
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 77.76
    Total Assets 1257.80
    Total Liabilities 1257.80
    Total Equity 776.02
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -9.60
    Return on Capital (%) -10.4
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 227.62
    Total Assets 7390.46
    Total Liabilities 7390.46
    Total Equity 5920.10
    Share Outstanding 11
    Price to Book Ratio 3.38
    Return on Assets (%) 0.26
    Return on Capital (%) 0.29
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 60.25
    Total Assets 1308.57
    Total Liabilities 1308.57
    Total Equity 397.74
    Share Outstanding 4
    Price to Book Ratio 0.00
    Return on Assets (%) -29.83
    Return on Capital (%) -40.69
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 79.76
    Total Assets 2008.44
    Total Liabilities 2008.44
    Total Equity 786.71
    Share Outstanding 4
    Price to Book Ratio 0.00
    Return on Assets (%) -39.78
    Return on Capital (%) -49.22
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 169.45
    Total Assets 2444.99
    Total Liabilities 2444.99
    Total Equity 1015.50
    Share Outstanding 3
    Price to Book Ratio 0.00
    Return on Assets (%) -9.39
    Return on Capital (%) -10.59
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 77.40
    Total Assets 1262.17
    Total Liabilities 1262.17
    Total Equity 778.55
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -9.60
    Return on Capital (%) -10.41
    Particulars MAR 2025 (Values in Cr)
    Net Income -67.75
    Cash from Operations -60.84
    Cash from Investing -201.08
    Cash from Financing 412.00
    Net change in Cash 143.07
    Free Cash Flow 67.30
    Particulars MAR 2024 (Values in Cr)
    Net Income -391.16
    Cash from Operations -107.21
    Cash from Investing 510.54
    Cash from Financing -390.54
    Net change in Cash 12.79
    Free Cash Flow -43.44
    Particulars MAR 2023 (Values in Cr)
    Net Income -799.83
    Cash from Operations -173.81
    Cash from Investing -67.71
    Cash from Financing 118.31
    Net change in Cash -112.28
    Free Cash Flow -129.81
    Particulars MAR 2022 (Values in Cr)
    Net Income -231.26
    Cash from Operations -415.95
    Cash from Investing -691.60
    Cash from Financing 1161.96
    Net change in Cash 54.47
    Free Cash Flow 239.23
    Particulars MAR 2021 (Values in Cr)
    Net Income -120.56
    Cash from Operations -116.71
    Cash from Investing -207.37
    Cash from Financing 380.95
    Net change in Cash 56.00
    Free Cash Flow 90.72
    Particulars MAR 2025 (Values in Cr)
    Net Income -22.14
    Cash from Operations -40.38
    Cash from Investing -300.03
    Cash from Financing 417.21
    Net change in Cash 69.89
    Free Cash Flow 45.92
    Particulars MAR 2024 (Values in Cr)
    Net Income -390.40
    Cash from Operations -108.98
    Cash from Investing 505.98
    Cash from Financing -384.22
    Net change in Cash 12.78
    Free Cash Flow -45.22
    Particulars MAR 2023 (Values in Cr)
    Net Income -799.11
    Cash from Operations -175.62
    Cash from Investing -65.68
    Cash from Financing 118.31
    Net change in Cash -112.05
    Free Cash Flow -133.78
    Particulars MAR 2022 (Values in Cr)
    Net Income -229.74
    Cash from Operations -419.66
    Cash from Investing -684.53
    Cash from Financing 1158.74
    Net change in Cash 54.54
    Free Cash Flow 229.94
    Particulars MAR 2021 (Values in Cr)
    Net Income -121.23
    Cash from Operations -114.87
    Cash from Investing -210.33
    Cash from Financing 380.97
    Net change in Cash 55.75
    Free Cash Flow 44.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.93 18.23 2.12 336.65 23.12 45.50
    BLISS GVS PHARMA LTD 493.60 39.74 4.39 5244.20 118.35 552.90
    CIPLA LTD 1475.00 33.30 3.46 119157.18 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 551.60 25.80 3.99 1623.41 256.40 564.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.93 30.72 5.65 336.65 23.12 45.50
    AMRUTANJAN HEALTH CARE LTD. 519.90 23.30 4.05 1503.06 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8091.35 105.74 23.17 20228.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 493.60 53.42 4.53 5244.20 118.35 552.90

    ONESOURCE SPECL PHARMA L shareholding pattern

    Holding
    26.94%
    30.47%
    19.19%
    23.38%
    37.23%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    ONESOURCE SPECL PHARMA L Technicals Summary

    1576.00 1.21 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 1576.50
    • 26 Days 1637.20
    • 10 Days 1606.80
    • 50 Days 1648.70
    • 12 Days 1613.90
    • 100 Days 1641.10
    • 20 Days 1630.10
    • 200 Days 1636.40
    1554.03 PIVOT
    First Support 1538.07 First Resistance 1573.07 Second Support 1519.03 Second Resistance 1589.03 Third Support 1503.07 Third Resistance 1608.07
    RSI 39.13 ADX 13.74 MACD -23.21 Williams % R -79.72 Commodity Channel Index (CCI) -143.92
    Date 2026-08-06 Week 129040.00 Same Day 141052.00 Month 164358.00
    1 Year -0.26 3 Year 0.32
    Over 1 Month
    -6.37% down
    Over 1 Year
    -17.05% down
    Over 3 Months
    -10.69% down
    Over 3 Years
    0.00% down
    Over 6 Months
    39.03% down
    Over 5 Years
    0.00% down

    ONESOURCE SPECL PHARMA L Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of OneSource Specialty Pharma Ltd?

    Answer Field

    OneSource Specialty Pharma Ltd share price is for NSE ₹ 1,576.00 & for BSE ₹ 1,568.00 as on Aug 07 2026 03:30 PM.

    What is the Market Cap of OneSource Specialty Pharma Ltd Share?

    Answer Field

    The market cap of OneSource Specialty Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 07 2026 03:30 PM.

    What is the 52 Week High and Low of OneSource Specialty Pharma Ltd?

    Answer Field

    The 52 Week High and Low of OneSource Specialty Pharma Ltd for NSE is ₹ 1,925.00 and ₹ 1,057.00 and for BSE is ₹ 1,924.00 and ₹ 1,075.00.

    What is 1 year return for OneSource Specialty Pharma Ltd?

    Answer Field

    The 1 year returns on the stock has been -17.05%.

    What is the P/E Ratio of OneSource Specialty Pharma Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM the price-to-earnings (PE) ratio for OneSource Specialty Pharma Ltd share is 373.70.

    What is the PB ratio of OneSource Specialty Pharma Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM, the price-to-book (PB) ratio for OneSource Specialty Pharma Ltd share is 518.95.

    How to Buy OneSource Specialty Pharma Ltd Share?

    Answer Field

    You can trade in OneSource Specialty Pharma Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy OneSource Specialty Pharma Ltd Share on Bajaj Broking App?

    Answer Field

    To buy OneSource Specialty Pharma Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “OneSource Specialty Pharma Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |